Thermo Fisher Scientific Inc.
TMO
$459.30
$6.701.48%
NYSE
| 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Net Income | 5.13% | 5.82% | 7.09% | 5.85% | 7.95% |
| Total Depreciation and Amortization | -5.64% | -10.55% | -12.82% | -13.15% | -12.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 137.31% | 135.77% | 94.75% | 60.49% | 52.01% |
| Change in Net Operating Assets | -47.00% | -377.04% | -321.47% | -314.77% | -586.60% |
| Cash from Operations | 1.82% | -9.80% | -15.92% | -18.93% | -8.84% |
| Capital Expenditure | -8.76% | -8.93% | -16.23% | -1.66% | -3.44% |
| Sale of Property, Plant, and Equipment | -36.92% | -22.81% | -33.33% | -48.45% | -23.53% |
| Cash Acquisitions | -312.16% | -28.90% | -28.90% | -244.55% | -227.62% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,237.50% | 207.69% | 134.13% | 107.12% | 108.04% |
| Cash from Investing | -187.71% | 30.71% | 21.15% | -13.88% | -7.64% |
| Total Debt Issued | 310.04% | 635.38% | 6.93% | -60.26% | -63.32% |
| Total Debt Repaid | 8.19% | 2.77% | 3.42% | 0.83% | 38.21% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -33.33% | 25.00% | -32.10% | 0.00% | 0.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -8.71% | -9.09% | -9.30% | -9.91% | -10.35% |
| Other Financing Activities | -34.62% | -53.61% | -108.00% | -69.89% | -10.34% |
| Cash from Financing | 159.06% | 126.52% | -18.38% | -294.23% | -78.00% |
| Foreign Exchange rate Adjustments | 505.26% | 393.41% | -100.00% | 546.43% | -162.07% |
| Miscellaneous Cash Flow Adjustments | -300.00% | -- | -200.00% | -100.00% | -- |
| Net Change in Cash | 33.78% | 243.92% | -77.50% | -163.24% | -166.72% |